AMRN Q3 2020 Earnings — Amarin Corporation plc Revenue & Financial Results | Market Cap Arena

AMRNAmarin Corporation plc

$335M

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$156M+39.2% YoY

Gross Profit

$123M78.9% margin

Operating Income

-$7M-4.4% margin

Net Income

-$7M-4.3% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+15.7%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$11M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$960M

Total Liabilities

$353M

Stockholders' Equity

$607M

Cash & Equivalents

$207M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$156M	$112M	+39.2%
Gross Profit	$123M	$87M	+41.9%
Operating Income	-$7M	-$5M	-53.6%
Net Income	-$7M	-$3M	-96.1%

Revenue Segments

Product

$155M99%

Licensing And Royalty

$1M1%